(CNDX) iShares NASDAQ 100 USD - Ratings and Ratios
Technology, Stocks, Growth, Equity, Funds
Description: CNDX iShares NASDAQ 100 USD
The iShares NASDAQ100 UCITS ETF USD (Acc) is a US Large-Cap Growth Equity ETF listed in the Netherlands with the ticker symbol CNDX. It tracks the Morningstar US LM Brd Growth NR USD index, providing exposure to a broad range of large-cap growth stocks in the US market.
With Assets Under Management (AUM) of approximately €15.86 billion, this ETF is a significant player in the US Large-Cap Growth Equity category. The funds size indicates a high level of investor confidence and liquidity, making it an attractive option for investors seeking exposure to this specific market segment.
To evaluate the ETFs performance, key metrics such as tracking error, expense ratio, and dividend yield (if applicable) should be considered. Although not provided, these KPIs are crucial in assessing the funds ability to replicate its underlying index and its overall cost-effectiveness. A lower tracking error and expense ratio generally indicate better performance.
Given its focus on large-cap growth stocks, this ETF is likely to be heavily weighted in technology and other growth-oriented sectors. Investors should be aware of the potential risks associated with growth investing, including higher volatility and the potential for significant drawdowns during market downturns.
To make informed investment decisions, its essential to analyze the ETFs holdings, sector allocation, and historical performance. By doing so, investors can better understand the funds risk profile and potential for long-term growth, ultimately determining whether it aligns with their investment objectives and risk tolerance.
CNDX ETF Overview
| Market Cap in USD | 22,850m |
| Category | US Large-Cap Growth Equity |
| TER | 0.30% |
| IPO / Inception | 2010-01-26 |
CNDX ETF Ratings
| Growth Rating | 53.0% |
| Fundamental | - |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -0.50% |
| Analyst Rating | - |
CNDX Dividends
Currently no dividends paidCNDX Growth Ratios
| Growth Correlation 3m | 85.1% |
| Growth Correlation 12m | 10.7% |
| Growth Correlation 5y | 86.3% |
| CAGR 5y | 15.72% |
| CAGR/Max DD 5y | 0.50 |
| Sharpe Ratio 12m | 1.58 |
| Alpha | 1.78 |
| Beta | 0.879 |
| Volatility | 17.67% |
| Current Volume | 3.9k |
| Average Volume 20d | 2.4k |
| Stop Loss | 1117 (-3%) |
| Signal | -1.74 |
What is the price of CNDX shares?
Over the past week, the price has changed by +0.44%, over one month by +0.98%, over three months by +5.13% and over the past year by +18.64%.
Is iShares NASDAQ 100 USD a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNDX is around 1143.39 EUR . This means that CNDX is currently overvalued and has a potential downside of -0.71%.
Is CNDX a buy, sell or hold?
What are the forecasts/targets for the CNDX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1283.5 | 11.5% |
CNDX Fundamental Data Overview
Market Cap EUR = 19.60b (19.60b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 19.60b EUR (19.60b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 19.60b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 19.60b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(19.60b)/V(0.0) * Re(9.25%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 9.25% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)